Total Teams – Dracen Pharmaceutical

Barbara Slusher, M.A.S., Ph.D.

Barbara Slusher is Professor of Neurology (primary), Psychiatry, Neuroscience, Medicine and Oncology at Johns Hopkins School of Medicine and the Director of the Johns Hopkins Drug Discovery program (https://drugdiscovery.jhu.edu/). Before joining Johns Hopkins, she spent 18 years in the pharmaceutical Continue reading →

Rana Rais, Ph.D.

Rana Rais is a Neurology faculty member at the Johns Hopkins School of Medicine and Director of the Drug Metabolism and Pharmacokinetics group of Johns Hopkins Drug Discovery (JHDD). She received her Ph.D. in Pharmaceutical Sciences and has substantial experience Continue reading →

Jonathan Powell, M.D., Ph.D.

Jonathan Powell is a Professor of Oncology and Pharmacology at Johns Hopkins University School of Medicine. He received his AB from Dartmouth College and his M.D. Ph.D. from Emory University School of Medicine. His Post-graduate clinical training included the Osler Continue reading →

Pavel Majer, Ph.D.

Dr Majer is Group Leader for medicinal Chemistry at the Institute of Organic Chemistry and Biochemistry (IOCB) at the Academy of Sciences of the Czech Republic since 2011. He developed orally active prodrugs of potent inhibitor Continue reading →

Dean Felsher, Ph.D., M.D.

Dr. Dean Felsher is a Professor in the Division of Oncology, Departments of Medicine and Pathology at Stanford University School of Medicine. He is currently the Founding Director of the Translational and Applied Medicine Program, Director of Oncology Research, Continue reading →

Chi Van Dang, M.D., Ph.D.

Dr. Chi Van Dang is scientific director of the Ludwig Institute for Cancer Research and Professor at The Wistar Institute. His research helped define the complex functions of the MYC oncogene, a central switch in human cancer, identifying key domains Continue reading →

Drew Pardoll

Jonathan Leff

Robert Jackson

Francois Lafleur, M.P.H.

Mr. Lafleur brings more than 25 year of experience in pharmaceutical and biotech industries as well as medical and clinical to Dracen. Prior to joining Dracen, Mr. Lafleur worked at several leading biopharmaceutical companies including Ipsen, Helsinn, Celgene, Pfizer, Continue reading →